TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 184 filers reported holding TG THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $241,000 | -7.3% | 5,000 | 0.0% | 0.02% | -13.8% |
| Q4 2020 | $260,000 | +33.3% | 5,000 | -50.0% | 0.03% | +7.4% |
| Q2 2020 | $195,000 | +99.0% | 10,000 | 0.0% | 0.03% | +92.9% |
| Q1 2020 | $98,000 | -65.1% | 10,000 | -80.0% | 0.01% | -53.3% |
| Q3 2019 | $281,000 | -35.1% | 50,000 | 0.0% | 0.03% | -36.2% |
| Q2 2019 | $433,000 | +7.7% | 50,000 | 0.0% | 0.05% | +11.9% |
| Q1 2019 | $402,000 | +96.1% | 50,000 | 0.0% | 0.04% | +82.6% |
| Q4 2018 | $205,000 | -77.1% | 50,000 | -68.8% | 0.02% | -74.7% |
| Q3 2018 | $896,000 | -57.4% | 160,000 | 0.0% | 0.09% | -60.8% |
| Q2 2018 | $2,104,000 | -7.4% | 160,000 | 0.0% | 0.23% | -13.1% |
| Q1 2018 | $2,272,000 | +73.2% | 160,000 | 0.0% | 0.27% | +72.3% |
| Q4 2017 | $1,312,000 | -30.8% | 160,000 | 0.0% | 0.16% | -36.7% |
| Q3 2017 | $1,896,000 | +214.4% | 160,000 | +166.7% | 0.24% | +202.5% |
| Q2 2017 | $603,000 | -13.7% | 60,000 | 0.0% | 0.08% | -18.2% |
| Q1 2017 | $699,000 | – | 60,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |